0000899243-16-024953.txt : 20160712
0000899243-16-024953.hdr.sgml : 20160712
20160712162139
ACCESSION NUMBER: 0000899243-16-024953
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160712
FILED AS OF DATE: 20160712
DATE AS OF CHANGE: 20160712
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celator Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001327467
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202680869
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303B COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 243-0123
MAIL ADDRESS:
STREET 1: 303B COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOLLICA JOSEPH A
CENTRAL INDEX KEY: 0001126489
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36179
FILM NUMBER: 161764154
MAIL ADDRESS:
STREET 1: 10555 SCIENCE CENTER DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-07-12
1
0001327467
Celator Pharmaceuticals Inc
CPXX
0001126489
MOLLICA JOSEPH A
C/O CELATOR PHARMACEUTICALS, INC.
200 PRINCETONSOUTH CORP. CENTER, STE 180
EWING
NJ
08628
1
0
0
0
Stock Option (right to buy)
3.37
2016-07-12
4
D
0
26668
26.88
D
2017-12-04
Common Stock
26668
0
D
Stock Option (right to buy)
3.116
2016-07-12
4
D
0
28000
27.134
D
2023-06-03
Common Stock
28000
0
D
Stock Option (right to buy)
2.80
2016-07-12
4
D
0
14000
27.45
D
2024-06-12
Common Stock
14000
0
D
Stock Option (right to buy)
2.60
2016-07-12
4
D
0
14000
27.65
D
2025-06-11
Common Stock
14000
0
D
The option (which was vested in full), was canceled in the merger under the Agreement and Plan of Merger dated as of May 27, 2016 among Jazz Pharmaceuticals plc, Plex Merger Sub, Inc. and the Issuer (the "Merger") in exchange for a cash payment, representing the difference between the exercise price per share of the option and $30.25, the purchase price per share of Issuer common stock in the Merger.
The option (which had provided for vesting as follows: (i) 9,334 options vest on June 3, 2014; (ii) 16,331 shares vest in seven consecutive quarterly installments of 2,333 shares each on the 3rd day of each respective month, beginning September 3, 2014 and continuing through March 3, 2016 and (iii) 2,335 options vest on June 3, 2016) was canceled in the in exchange for a cash payment, representing the difference between the exercise price per share of the option and $30.25, the purchase price per share of Issuer common stock in the Merger, multiplied by the number of shares.
The option (which had provided for vesting as follows: (i) 4,666 options vest on June 12, 2015; (ii) 8,162 shares vest in seven consecutive quarterly installments of 1,166 shares each on the 12th day of each respective month, beginning September 12, 2015 and continuing through March 12, 2017 and (iii) 1,172 options vest on June 12, 2017) was canceled in the in exchange for a cash payment, representing the difference between the exercise price per share of the option and $30.25, the purchase price per share of Issuer common stock in the Merger, multiplied by the number of shares.
The option (which had provided for vesting as follows: (i) 4,667 options vest on June 11, 2016; (ii) 8,169 shares vest in seven consecutive quarterly installments of 1,167 shares each on the 11th day of each respective month, beginning September 11, 2016 and continuing through March 11, 2018 and (iii) 1,164 options vest on June 11, 2018) was canceled in the in exchange for a cash payment, representing the difference between the exercise price per share of the option and $30.25, the purchase price per share of Issuer common stock in the Merger, multiplied by the number of shares.
/s/ Fred M. Powell, Attorney-in-Fact
2016-07-12